Puxitatug samrotecan (P-Sam), an investigational antibody-drug conjugate (ADC) targeting B7-H4-expressing tumors, showed ...

In what's expected to soon be commonplace, artificial intelligence is being harnessed to pick up signs of cancer more ...

Clinicians should adopt a risk-based, rather than biopsy-first, approach to encourage biopsy acceptance and improve early ...

Thousands of women claim hair relaxers cause cancer, citing studies linking them to increased risks. Legal battles grow ...

One of Australia's most common gynecological cancers could be detected sooner and more accurately thanks to a specialized artificial intelligence (AI) model, new research shows.

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer, data ...

The following is a summary of “Geographic and racial disparities in the quality of surgical care among patients with ...

Byline: Umesh Isalkar Poonam was relieved when MRI and PET scans confirmed her endometrial cancer was in the early, ...

Thousands of Black women across the country are suing chemical relaxer manufacturers, alleging the products caused cancer.

Neoadjuvant nivolumab has demonstrated efficacy in patients with mismatch repair-deficient, surgically resectable endometrial cancer.